m+Medelevator.RU
← Поиск публикаций
Neurosurgical review · 2025

Efficacy and safety of external ventricular drainage in the treatment of space-occupying cerebellar infarction.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Wu Yasong, Wu Zengbao, Fan Ting, Lian Lifei, Chen Bo, Tan Zhoubin, Niu Hongquan, Han Lin, Wan Xueyan

Аннотация

To evaluate the efficacy and safety of external ventricular drainage (EVD) in managing patients with space-occupying cerebellar infarction. The 48 patients were divided into two groups: the EVD group and the non-EVD group. The outcomes of the patient were assessed using the modified Rankin Scale (mRS), with scores of ≤ 3 indicating a favorable prognosis. Among the 48 patients, 29 underwent EVD, while 19 were in the non-EVD group. This non-EVD group included 14 patients who underwent suboccipital decompression and 5 who underwent suboccipital decompression combined with necrosectomy. In the EVD group, 20 patients had a favorable prognosis and 9 had a poor prognosis, with 6 deaths. In the non-EVD group, 16 patients had a favorable prognosis and 3 had a poor prognosis, with 3 deaths. No statistically significant differences were observed between the two groups. Multivariate logistic regression analysis revealed that a Glasgow Coma Scale (GCS) score < 9 (OR 9.5, 95% CI 1.5-77.0, P = 0.05), cerebral infarction (OR 15.6, 95% CI 2.3-144.0, P = 0.03), and the requirement for postoperative ventilatory support (OR 12.7, 95% CI 2.7-79.4, P = 0.01) were independent risk factors for poor patient outcomes. For patients with space-occupying cerebellar infarction, EVD might be an effective and safe treatment option. However, its efficacy and safety require further confirmation through prospective randomized clinical trials.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты